...
首页> 外文期刊>EFSA Journal >Scientific Opinion on the substantiation of health claims related to Lactobacillus rhamnosus LB21 NCIMB 40564 and decreasing potentially pathogenic intestinal microorganisms (ID 1064), digestive health (ID 1064), and reduction of mutans streptococci in the oral cavity (ID 1064) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
【24h】

Scientific Opinion on the substantiation of health claims related to Lactobacillus rhamnosus LB21 NCIMB 40564 and decreasing potentially pathogenic intestinal microorganisms (ID 1064), digestive health (ID 1064), and reduction of mutans streptococci in the oral cavity (ID 1064) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

机译:关于证实鼠李糖乳杆菌LB21 NCIMB 40564和减少潜在致病性肠道微生物(ID 1064),消化系统健康(ID 1064)以及减少口腔中变形链球菌的健康主张的科学意见ID(ID 1064),依据法规(EC)No 1924/2006的第13(1)条

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition andAllergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 ofRegulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claimsin relation to Lactobacillus rhamnosus LB21 NCIMB 40564 and decreasing potentially pathogenicintestinal microorganisms, “digestive health”, and reduction of mutans streptococci in the oral cavity.The scientific substantiation is based on the information provided by the Member States in theconsolidated list of Article 13 health claims and references that EFSA has received from MemberStates or directly from stakeholders.
机译:应欧盟委员会的要求,要求营养产品,营养和过敏问题小组根据1924/2006号法规(EC)第13条就健康声明清单提供科学意见。该意见涉及与鼠李糖乳杆菌LB21 NCIMB 40564有关的健康主张的科学依据,并减少了潜在的病原性肠道微生物,“消化健康”和减少口腔中链球菌的变异。科学依据是根据会员国提供的信息EFSA已从成员国或直接从利益相关者那里收到的第13条健康声明和参考文献的综合清单中。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号